careers news & media events contact info site map  
  torrent   torrent pharmaceuticals limited  
Home  ::  Research & Development  :: Development Portfolio  


Development Portfolio::

Within a span of 5 years, the major achievements to the credit of the Torrent R&D Centre are the development of world class fermentation technology for Pen-G, synthesis of Omeprazole, Sparfloxacin, Nicorandil, Lamotrigine, Sertraline, Sildenafil Citrate, Repaglinide, Rosiglitazone, Clopidogrel, Sibutramine and Cerivastatin and the introduction of low dose combination of Lisinopril and Hydrochlorothiazide(Listril Plus/Forte), matching international quality standards. This rational combination was specifically formulated keeping in mind the needs of Indian patients.

First Time Introduction by the Centre :

  • Fluconazole 0.3% Eye Drops for the first time in the world.
  • Esomeprazole (20,40mg) Multi Unit Particulate System (Pellets compressed in the form of tablet) for the first time in India.
  • Rosiglitazoe 2mg/4mg Immediate Release + Metformin 500mg Sustanded - Release Dual Retard Technology launched in the form of Inlay Tablet for the first time of India.
  • Few Non-Conventional Dosage Forms Developed
Dilzem CD (Diltiazem) Controlled Release Pallets
Alprax Plus (Alprazolam SR + Sertraline) Sustained Release + Immediate Release Bi Component Capsule
Lamitor DT (Lamotrigine) Dispersible Tablet
Calcigard (Nifedipine) Soft Gelatin Capsule
Valparin Alkalets (Sodium Valproate) Enteric Coated Tablet
Valparin Chrono (Sodium Valproate) Sustained Release Matrix Tablet
Fegem (Iron Polymaltose Complex) Chewable Tablet
Droxil Ready (Cefadroxil) Ready To Use Suspension
Dilzem Inj (Diltiazem) Life Saving Injectable
Nikoran IV (Nicorandil) Lyophilized Injectable
Nexpro (Esomeprazole) Pellets compressed in Tablet
Enselin MF (Rosiglitazone IR+ Metformin SR) Dual Retard Technology in form of Inlay Tablet




Copyright © 2003
careers faq news & media events contact info site map